Clinical Trial Details
EORTC-20971-22997-LYMG-ROG
Back to Clinical Trials Database
A Phase III randomized study on low-dose total body irradiation and involved field radiotherapy in patients with localized, stages I and II, low grade non-Hodgkin's lymphoma
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 25-Jan-2001 Date Step1 close: 02-Mar-2009 |
Data management at EORTC | Yes |
Design |
Phase 3 Randomized open label |
Targeted Sample size | EORTC Groups: 344 - All Groups: 344 |
Treatment |
Radiotherapy |
Study Staff |
Catherine Fortpied (Statistician) , EORTC Headquarters, Brussels Cedric Mallien (Clinical Operations Manager) , EORTC Headquarters, Brussels Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels Ward Sents (Clinical Scientist) , EORTC Headquarters, Brussels Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels |
Type of cancer | Non Hodgkins Lymphoma |
Participating groups |
EORTC Lymphoma Group EORTC Radiation Oncology Group |
Recruiting centers |
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia (Brescia, Italy) Institut du Cancer de Montpellier (MONTPELLIER CEDEX 5, France) Instituut Verbeeten (Tilburg, Netherlands) Maastro Clinic - Maastricht Radiation Oncology (Maastricht, Netherlands) Medisch Spectrum Twente (Enschede, Netherlands) National Cancer Institute - Cairo (Cairo, Egypt) Rigshospitalet (Copenhagen, Denmark) The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands) UMC-Academisch Ziekenhuis Utrecht (Utrecht, Netherlands) University Hospital Centre Zagreb (Zagreb, Croatia) |
Centers to be activated |
A.Z. St. Jan (Brugge, Belgium) General Teaching Hospital In Prague (Prague 2, Czech Republic) Institut Jules Bordet (Anderlecht, Belgium) Royal Wolverhampton NHS - New Cross Hospital (Wolverhampton West Midlands, United Kingdom) |
Protocol summary | http://clinicaltrials.gov/study/NCT00014326 |
NCT number | NCT00014326 |
Financial Support | EORTC HQ |